- Home
- OLMA vs COO Comparison
OLMA vs COO Comparison
Compare OLMA & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- COO
- Stock Information
- Founded
- OLMA 2006
- COO 1980
- Country
- OLMA United States
- COO United States
- Employees
- OLMA N/A
- COO 16000
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- COO Ophthalmic Goods
- Sector
- OLMA Health Care
- COO Health Care
- Exchange
- OLMA Nasdaq
- COO Nasdaq
- Market Cap
- OLMA 299.7M
- COO 14.6B
- IPO Year
- OLMA 2020
- COO N/A
- Fundamental
- Price
- OLMA $4.65
- COO $74.77
- Analyst Decision
- OLMA Strong Buy
- COO Strong Buy
- Analyst Count
- OLMA 4
- COO 9
- Target Price
- OLMA $24.50
- COO $99.67
- AVG Volume (30 Days)
- OLMA 825.6K
- COO 2.9M
- Earning Date
- OLMA 08-05-2025
- COO 08-27-2025
- Dividend Yield
- OLMA N/A
- COO N/A
- EPS Growth
- OLMA N/A
- COO 21.77
- EPS
- OLMA N/A
- COO 2.07
- Revenue
- OLMA N/A
- COO $3,988,200,000.00
- Revenue This Year
- OLMA N/A
- COO $6.79
- Revenue Next Year
- OLMA N/A
- COO $6.44
- P/E Ratio
- OLMA N/A
- COO $36.12
- Revenue Growth
- OLMA N/A
- COO 6.88
- 52 Week Low
- OLMA $2.86
- COO $65.00
- 52 Week High
- OLMA $16.62
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- OLMA 52.46
- COO 55.66
- Support Level
- OLMA $4.38
- COO $69.01
- Resistance Level
- OLMA $5.01
- COO $77.06
- Average True Range (ATR)
- OLMA 0.30
- COO 1.65
- MACD
- OLMA 0.05
- COO 0.85
- Stochastic Oscillator
- OLMA 63.64
- COO 74.38
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.